US Patent 9682052 Neprilysin inhibitors
Patent 9682052 was granted and assigned to Theravance on June, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 26 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+84 characters)
Article
Patent abstract
In one aspect, the invention relates to compounds having the formula:
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09682052 Neprilysin inhibitors US Patent 9682052 Neprilysin inhibitors
Infobox
Patent Number
0968205200
Patent Number
968205200
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
096820520
Date of Patent
June 20, 2017
0Patent Application Number
148388420
Date Filed
August 28, 2015
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
096820520
Date of Patent
June 20, 2017
0Patent Application Number
148388420
Date Filed
August 28, 2015
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 12 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09682052 Neprilysin inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09682052
Date of patent
June 20, 2017
Patent application number
14838842
Date Filed
August 28, 2015
Patent primary examiner
Find more entities like US Patent 9682052 Neprilysin inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
